Faculty

Institution

Unit

Venue

James Economou

Professor

University of California, Los Angeles

Affiliations

David Geffen School of Medicine

Mimg

Molecular & Medical Pharmacology

the College

Microbiology, Immunology, and Molecular Genetics

Molecular, Cell, and Developmental Biology

James Economou is currently serving as a David Geffen School Of Medicine Professor at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

James Economou

University of California, Los Angeles

Professor

You can click a keyword to filter the displayed items

immunology cancer immunotherapy oncology cancer research immunotherapy medicine melanoma dermatology tumor biology immune responses cellular therapy medicinal research clinical immunology cell biology cancer biology cancer care cancer cells cytokines cancer treatment cancer immunosurveillance cellular immune responses cell transplantation surgical oncology adaptive immune system tumor targeting gene therapy molecular cancer hepatocellular carcinoma skin cancer metastatic melanoma tumor microenvironment leukemia cancer discovery oncogenes clinical transplantation viral oncology cell therapy dendritic cells innate immune system tumor suppressors liver cancer t-regulatory cell cell death cell research enzyme inhibition gene transfer cancer management lymphoid neoplasia cancer genetics dendritic cell vaccination vascular biology medical virology cell regulation hla typing immune checkpoint inhibitors anti-cancer agents molecular immunology human melanoma radiation biology clinical medicine lymphocyte development cancer genomics clinical mycology determinant spreading tumor necrosis factor radiation therapy melanoma antigen human peripheral monocytes histone deacetylase inhibitor cytokine gene transfer radiofrequency ablation liver tumors large peritumoral vessels gene transfer methods human dendritic cells cellular immunotherapy

Notable Scholarly Works

Notable Federal Grants

Collaborators

Roadmap for Research and Scholarship in General Surgery Residency Training. Annals of Surgery (2024)

Mary T. HawnJeff B. MatthewsGinny L. BumgardnerJames EconomouKamal ItaniRachel KelzThomas TracyMartha A. Zeiger

surgerygeneral surgery

Roadmap for Research and Scholarship in General Surgery Residency Training: Report of the Research Subcommittee of Blue Ribbon Committee II on Surgical Education and Training. Ann Surg. (2024)

surgeryprogram evaluationsurgical trainingresearch subcommitteesurgical specialtysurgical educationeducationprofessional developmentmedical education

Data From Adoptive Transfer of Mart-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients With Metastatic Melanoma. (2023)

Thinle ChodonBegoña Comin-AnduixBartosz ChmielowskiRichard C. KoyaZhongqi WuMartin AuerbachCharles NgEarl AvramisElizabeth SejaArturo VillanuevaTara A. McCannelAkira IshiyamaJohannes CzerninCaius G. RaduXiaoyan WangDavid W. GjertsonAlistair J. CochranKenneth CornettaDeborah J.L. WongPaula Kaplan-LefkoOmid HamidWolfram SamlowskiPeter A. CohenGregory A. DanielsBijay MukherjiLili YangJerome A. ZackDonald B. KohnJames R. HeathJohn A. GlaspyOwen N. WitteDavid BaltimoreJames S. EconomouAntoni Ribas

cellular immune responsesadoptive transferdata sciencetumor targetingadaptive immune systemcancer researchlymphoid neoplasiacancer immunotherapyimmunotherapyimmunologyreceptorspharmacologyclinical immunologymetastatic melanomacellular therapyoncologymedicinal researchcell transplantationclinical transplantationdendritic cell vaccination

Data From Ctla4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans. (2023)

Rong Rong HuangJason JalilJames S. EconomouBartosz ChmielowskiRichard C. KoyaStephen MokHooman SazegarElizabeth SejaArturo VillanuevaJesus Gomez-NavarroJohn A. GlaspyAlistair J. CochranAntoni Ribas

immunologymedicinepharmacologycancer researchcancer immunotherapyoncologyactivated lymphocytesimmunotherapy

Data From Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor Laq824. (2023)

Dan D. VoRobert M. PrinsJonathan L. BegleyTimothy R. DonahueLilah F. MorrisKevin W. BruhnPilar de la RochaMeng-Yin YangStephen MokHermes J. GarbanNoah CraftJames S. EconomouFrancesco M. MarincolaEna WangAntoni Ribas

tumor targetingenhanced antitumor activitymolecular cancercancer immunosurveillanceanti-cancer agentsdermatologyleukemiaadoptive t-cell transfercancer researchcancer immunotherapydrug targetingcancer treatmenttumor biologyimmunotherapyimmunologyenzyme inhibitionpharmacologyoncologymedicinal researchadjunctive usecellular therapy

Supplementary Data From Immunotherapy Resistance by Inflammation-Induced Dedifferentiation. (2023)

Arnav MehtaYeon Joo KimLidia RobertJennifer TsoiBegoña Comin-AnduixBeata Berent-MaozAlistair J. CochranJames S. EconomouPaul C. TumehCristina Puig-SausAntoni Ribas

immunologysupplementary dataimmunotherapy resistanceinflammation-induced dedifferentiationimmunotherapy

Supplementary Figure 1 From Proteasome Inhibition Blocks Nf-κB and Erk1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to Tcr-Engineered Ctls. (2023)

Ali R. JazirehiJames S. Economou

tcr-engineered ctlsmelanomaresistant human melanomaproteome researchhost specificityproteasome inhibition blocksmolecular biologycancer cellstumor microenvironmenttumor biology

Supplementary Figures 1-5 From Molecular Mechanism of Mart-1 Sup + /Sup /a*0201 Sup + /Sup Human Melanoma Resistance to Specific Ctl-Killing Despite Functional Tumor–Ctl Interaction. (2023)

Ali R. JazirehiStavroula BaritakiRichard C. KoyaBenjamin BonavidaJames S. Economou

tumor targetingdermatologypharmacologymelanomadisease mechanismscancer researchmolecular cancermolecular regulationtumor suppressorscancer immunotherapytherapeutic targetsmolecular biologymedicinal researchmolecular mechanismtumor biology

Supplementary Figures S1-S2 From Intratumoral Immune Cell Infiltrates, Foxp3, and Indoleamine 2,3-Dioxygenase in Patients With Melanoma Undergoing Ctla4 Blockade. (2023)

Antoni RibasBegoña Comin-AnduixJames S. EconomouTimothy R. DonahuePilar de la RochaLilah F. MorrisJason JalilVivian B. DissetteItsushi Peter ShintakuJohn A. GlaspyJesus Gomez-NavarroAlistair J. Cochran

immunologyhematological malignanciesdermatologyleukemiapharmacologyenzyme inhibitionmelanomaclinical immunologytumor targetingcancer researchtumor suppressorscancer immunotherapyoncologyimmunotherapyinflammation

Supplementary Methods, Figure Legends, Table 1 From Adoptive Transfer of Mart-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients With Metastatic Melanoma. (2023)

immunologypharmacologyclinical immunologycell therapycancer researchmetastatic melanomalymphoid neoplasiacancer immunotherapycellular therapyclinical researchadoptive transfertumor biologyhealth sciencessupplementary methodsimmunotherapydendritic cell vaccination

1
2
3
4
5
15
10 / page

James Economou

Professor

University of California, Los Angeles

Affiliations

David Geffen School of Medicine

Mimg

Molecular & Medical Pharmacology

the College

Microbiology, Immunology, and Molecular Genetics

Molecular, Cell, and Developmental Biology

James Economou is currently serving as a David Geffen School Of Medicine Professor at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

James Economou

University of California, Los Angeles

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Roadmap for Research and Scholarship in General Surgery Residency Training. Annals of Surgery (2024)

Mary T. HawnJeff B. MatthewsGinny L. BumgardnerJames EconomouKamal ItaniRachel KelzThomas TracyMartha A. Zeiger

surgerygeneral surgery

Roadmap for Research and Scholarship in General Surgery Residency Training: Report of the Research Subcommittee of Blue Ribbon Committee II on Surgical Education and Training. Ann Surg. (2024)

surgeryprogram evaluationsurgical trainingresearch subcommitteesurgical specialtysurgical educationeducationprofessional developmentmedical education

Data From Adoptive Transfer of Mart-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients With Metastatic Melanoma. (2023)

Data From Ctla4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans. (2023)

Rong Rong HuangJason JalilJames S. EconomouBartosz ChmielowskiRichard C. KoyaStephen MokHooman SazegarElizabeth SejaArturo VillanuevaJesus Gomez-NavarroJohn A. GlaspyAlistair J. CochranAntoni Ribas

immunologymedicinepharmacologycancer researchcancer immunotherapyoncologyactivated lymphocytesimmunotherapy

Data From Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor Laq824. (2023)

Supplementary Data From Immunotherapy Resistance by Inflammation-Induced Dedifferentiation. (2023)

Arnav MehtaYeon Joo KimLidia RobertJennifer TsoiBegoña Comin-AnduixBeata Berent-MaozAlistair J. CochranJames S. EconomouPaul C. TumehCristina Puig-SausAntoni Ribas

immunologysupplementary dataimmunotherapy resistanceinflammation-induced dedifferentiationimmunotherapy

Supplementary Figure 1 From Proteasome Inhibition Blocks Nf-κB and Erk1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to Tcr-Engineered Ctls. (2023)

Ali R. JazirehiJames S. Economou

tcr-engineered ctlsmelanomaresistant human melanomaproteome researchhost specificityproteasome inhibition blocksmolecular biologycancer cellstumor microenvironmenttumor biology

Supplementary Figures 1-5 From Molecular Mechanism of Mart-1 Sup + /Sup /a*0201 Sup + /Sup Human Melanoma Resistance to Specific Ctl-Killing Despite Functional Tumor–Ctl Interaction. (2023)

Ali R. JazirehiStavroula BaritakiRichard C. KoyaBenjamin BonavidaJames S. Economou

Supplementary Figures S1-S2 From Intratumoral Immune Cell Infiltrates, Foxp3, and Indoleamine 2,3-Dioxygenase in Patients With Melanoma Undergoing Ctla4 Blockade. (2023)

Supplementary Methods, Figure Legends, Table 1 From Adoptive Transfer of Mart-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients With Metastatic Melanoma. (2023)

1
2
3
4
5
15
10 / page

Similar Faculty Members

Lili Yang

Institution

University of California, Los Angeles

immunology

cancer immunotherapy

Joshua C. Doloff

Institution

Johns Hopkins University

biomedical engineering

immunology

Xue-Feng Bai

Institution

Ohio State University

cellular immune response

cancer immunotherapy

Krishnendu Krish Roy

Institution

Vanderbilt University

cellular therapy

immune response

Yukai He

Institution

Augusta University

cellular therapy

immunology

Esma Yolcu

Institution

University of Missouri

stem cell

stem-cell therapy

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Christian Capitini

Institution

University of Wisconsin–Madison

stem cell

cell therapy

Markus Frank

Institution

Harvard University

blood diseases

aging cell

Saar I. Gill

Institution

University of Pennsylvania

immunology

medicine

Similar Faculty Members

Lili Yang

Institution

University of California, Los Angeles

immunology

cancer immunotherapy

Joshua C. Doloff

Institution

Johns Hopkins University

biomedical engineering

immunology

Xue-Feng Bai

Institution

Ohio State University

cellular immune response

cancer immunotherapy

Krishnendu Krish Roy

Institution

Vanderbilt University

cellular therapy

immune response

Yukai He

Institution

Augusta University

cellular therapy

immunology

Esma Yolcu

Institution

University of Missouri

stem cell

stem-cell therapy

Steven M. Dubinett

Institution

University of California, Los Angeles

oncology

cancer research

Christian Capitini

Institution

University of Wisconsin–Madison

stem cell

cell therapy

Markus Frank

Institution

Harvard University

blood diseases

aging cell

Saar I. Gill

Institution

University of Pennsylvania

immunology

medicine